Overview

Observational Study to Observe the Efficacy of LevemirĀ® (Insulin Detemir) in Patients With Type 2 Diabetes.

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to observe the efficacy of LevemirĀ® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. Furthermore the time period between diagnosis of type 2 diabetes and insulin initiation is evaluated.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc